The current study aimed to investigate whether the in vivo availability of central serotonin reuptake transporters (5-HTT) is associated with plasma levels of glycosylated hemoglobin (HbA1c) in non-diabetic humans with obesity. The gene discussed is SLC6A4; the disease is obesity due to melanocortin 4 receptor deficiency.